Contributors

Raymond Sawaya, MD, MD Anderson Cancer Center

Latest:

Improving Outcomes for Patients With Brain Metastases

Latest:

Advancing CML Management Towards an Ideal Patient Journey

The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.

Rashid K. Sayyid, MD, MSc

Latest:

The Role of Combination Therapy in mCRPC

Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.

Dr. Joan H. Schiller

Joan H. Schiller, MD, is the chair of the Steering Committee for Oncology Advocates United for Climate and Health – International.

Latest:

EPA Deregulation Means More Air Pollution and More Cancer Deaths

Recently, the American Lung Association released the 2025 “State of the Air” report.

Latest:

“Chillin’ Out” and Finding Our Cancer Community

After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the face of chronic blood cancers.

Julie Scott, D.N.P., ANP-B C

Latest:

Managing Chemotherapy-Induced Hair Loss

Many survivors see significant hair changes during cancer treatment, leaving a difficult reminder when they look in the mirror.

Kathleen Shuey, M.S., RN, ACON, ACNS-BC

Latest:

Helping the Team While Helping Others

Kathleen Shuey, M.S., RN, SCON, ACNS-BC, listens and guides us in the right direction in caring for our oncology population.

Dr. Berkay Simsek

Dr. Berkay Simsek is a research fellow in pathology at Brigham and Women’s Hospital.

Latest:

What Can Influence Immunotherapy Responses in Kidney Cancer?

TAMs may help predict response to PD-1 inhibitors in metastatic clear cell kidney cancer, Dr. Berkay Simsek reported at the 2025 Kidney Cancer Summit.

Dr. Eric K. Singhi

Latest:

FLAURA2 Shows Tagrisso Plus Chemo Boosts Survival in EGFR+ Lung Cancer

Dr. Eric Singhi sat down with CURE to break down the findings from the phase 3 FLAURA2 study, presented at the 2025 IASLC World Conference on Lung Cancer.

Carol Small is a survivor of breast cancer.

Latest:

Why I Regret Choosing Implants After Breast Cancer

If I’d gone flat after my mastectomy, I might be healthy now, but my breast implants led to more cancer, heart failure and years of pain.

Latest News

Understanding Your Diagnosis: An Overview of Leukemia

Looking Back on the Shock of a Multiple Myeloma Diagnosis

Beyond the Diagnosis: A Stage-by-Stage Guide to Multiple Myeloma Treatment

FDA Approves Bosaya and Aukelso Biosimilars for Solid Tumor Care

View More Latest News